{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:23:22Z","timestamp":1788341002060,"version":"build-2803163510"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"DOI":"10.1038\/s41434-026-00640-2","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:44:32Z","timestamp":1788335072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optogenetic vision restoration: translational barriers and emerging therapeutic strategies"],"prefix":"10.1038","author":[{"given":"Naoyuki","family":"Nakada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"640_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nmeth.f.324","volume":"8","author":"K Deisseroth","year":"2011","unstructured":"Deisseroth K. Optogenetics. Nat Methods. 2011;8:26\u201329.","journal-title":"Nat Methods"},{"key":"640_CR2","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nn.4091","volume":"18","author":"K Deisseroth","year":"2015","unstructured":"Deisseroth K. Optogenetics: 10 years of microbial opsins in neuroscience. Nat Neurosci. 2015;18:1213\u201325.","journal-title":"Nat Neurosci"},{"key":"640_CR3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41591-021-01351-4","volume":"27","author":"J-A Sahel","year":"2021","unstructured":"Sahel J-A, Boulanger-Scemama E, Pagot C, Arleo A, Galluppi F, Martel JN, et al. Partial recovery of visual function in a blind patient after optogenetic therapy. Nat Med. 2021;27:1223\u20139.","journal-title":"Nat Med"},{"key":"640_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41586-018-0076-4","volume":"557","author":"B Roska","year":"2018","unstructured":"Roska B, Sahel J-A. Restoring vision. Nature. 2018;557:359\u201367.","journal-title":"Nature"},{"key":"640_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.neuron.2012.10.002","volume":"76","author":"RH Masland","year":"2012","unstructured":"Masland RH. The neuronal organization of the retina. Neuron. 2012;76:266\u201380.","journal-title":"Neuron"},{"key":"640_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/ijms23010386","volume":"23","author":"G Kaur","year":"2021","unstructured":"Kaur G, Singh NK. The role of inflammation in retinal neurodegeneration and degenerative diseases. Int J Mol Sci. 2021;23:386.","journal-title":"Int J Mol Sci"},{"key":"640_CR7","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795\u2013809.","journal-title":"Lancet"},{"key":"640_CR8","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Heal. 2014;2:e106\u2013e116.","journal-title":"Lancet Glob Heal"},{"key":"640_CR9","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.21037\/atm-20-4726","volume":"9","author":"Y Nuzbrokh","year":"2020","unstructured":"Nuzbrokh Y, Ragi SD, Tsang SH. Gene therapy for inherited retinal diseases. Ann Transl Med. 2020;9:1278.","journal-title":"Ann Transl Med"},{"key":"640_CR10","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","volume":"9","author":"JD Adelson","year":"2021","unstructured":"Adelson JD, Bourne RRA, Briant PS, Flaxman SR, Taylor HRB, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Heal. 2021;9:e144\u2013e160.","journal-title":"Lancet Glob Heal"},{"key":"640_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuron.2006.02.026","volume":"50","author":"A Bi","year":"2006","unstructured":"Bi A, Cui J, Ma Y-P, Olshevskaya E, Pu M, Dizhoor AM, et al. Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration. Neuron. 2006;50:23\u201333.","journal-title":"Neuron"},{"key":"640_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.570909","volume":"14","author":"ME McClements","year":"2020","unstructured":"McClements ME, Staurenghi F, MacLaren RE, Cehajic-Kapetanovic J. Optogenetic gene therapy for the degenerate retina: recent advances. Front Neurosci. 2020;14:570909.","journal-title":"Front Neurosci"},{"key":"640_CR13","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/nn1525","volume":"8","author":"ES Boyden","year":"2005","unstructured":"Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci. 2005;8:1263\u20138.","journal-title":"Nat Neurosci"},{"key":"640_CR14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nmeth.2836","volume":"11","author":"NC Klapoetke","year":"2014","unstructured":"Klapoetke NC, Murata Y, Kim SS, Pulver SR, Birdsey-Benson A, Cho YK, et al. Independent optical excitation of distinct neural populations. Nat Methods. 2014;11:338\u201346.","journal-title":"Nat Methods"},{"key":"640_CR15","first-page":"041505","volume":"4","author":"W Wright","year":"2017","unstructured":"Wright W, Gajjeraman S, Batabyal S, Pradhan S, Bhattacharya S, Mahapatra V, et al. Restoring vision in mice with retinal degeneration using multicharacteristic opsin. Neurophotonics. 2017;4:041505\u2013041505.","journal-title":"Neurophotonics"},{"key":"640_CR16","doi-asserted-by":"publisher","unstructured":"Marshel JH, Kim YS, Machado TA, Quirin S, Benson B, Kadmon J, et al. Cortical layer\u2013specific critical dynamics triggering perception. Science 2019;365. https:\/\/doi.org\/10.1126\/science.aaw5202.","DOI":"10.1126\/science.aaw5202"},{"key":"640_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107716","volume":"26","author":"Y Katada","year":"2023","unstructured":"Katada Y, Yoshida K, Serizawa N, Lee D, Kobayashi K, Negishi K, et al. Highly sensitive visual restoration and protection via ectopic expression of chimeric rhodopsin in mice. iScience. 2023;26:107716.","journal-title":"iScience"},{"key":"640_CR18","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3390\/biom15070940","volume":"15","author":"J Huang","year":"2025","unstructured":"Huang J, Li J, Xu X, Li K. Adeno-associated virus vectors in retinal gene therapy: challenges, innovations, and future directions. Biomolecules. 2025;15:940.","journal-title":"Biomolecules"},{"key":"640_CR19","doi-asserted-by":"publisher","first-page":"11372","DOI":"10.1128\/JVI.01327-07","volume":"81","author":"M Allocca","year":"2007","unstructured":"Allocca M, Mussolino C, Garcia-Hoyos M, Sanges D, Iodice C, Petrillo M, et al. Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors. J Virol. 2007;81:11372\u201380.","journal-title":"J Virol"},{"key":"640_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1167\/iovs.63.3.11","volume":"63","author":"X Qian","year":"2022","unstructured":"Qian X, Liu H, Fu S, Lu J, Hung Y-T, Turner C, et al. AAV8-mediated gene therapy rescues retinal degeneration phenotype in a Tlcd3b knockout mouse model. Investig Ophthalmol Vis Sci. 2022;63:11.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"640_CR21","doi-asserted-by":"publisher","first-page":"189ra76","DOI":"10.1126\/scitranslmed.3005708","volume":"5","author":"D Dalkara","year":"2013","unstructured":"Dalkara D, Byrne LC, Klimczak RR, Visel M, Yin L, Merigan WH, et al. In vivo\u2013directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Sci Transl Med. 2013;5:189ra76.","journal-title":"Sci Transl Med"},{"key":"640_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4014797","volume":"2021","author":"ME McClements","year":"2021","unstructured":"McClements ME, Staurenghi F, Visel M, Flannery JG, MacLaren RE, Cehajic-Kapetanovic J. AAV-induced expression of human rod and cone opsin in bipolar cells of a mouse model of retinal degeneration. BioMed Res Int. 2021;2021:4014797.","journal-title":"BioMed Res Int"},{"key":"640_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/hum.2016.111","volume":"28","author":"PS Ramachandran","year":"2017","unstructured":"Ramachandran PS, Lee V, Wei Z, Song JY, Casal G, Cronin T, et al. Evaluation of dose and safety of AAV7m8 and AAV8BP2 in the non-human primate retina. Hum Gene Ther. 2017;28:154\u201367.","journal-title":"Hum Gene Ther"},{"key":"640_CR24","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.4103\/1673-5374.306063","volume":"16","author":"M Ross","year":"2021","unstructured":"Ross M, Ofri R. The future of retinal gene therapy: evolving from subretinal to intravitreal vector delivery. Neural Regen Res. 2021;16:1751\u20139.","journal-title":"Neural Regen Res"},{"key":"640_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3389\/fnins.2017.00521","volume":"11","author":"KS Hanlon","year":"2017","unstructured":"Hanlon KS, Chadderton N, Palfi A, Fernandez AB, Humphries P, Kenna PF, et al. A novel retinal ganglion cell promoter for utility in AAV vectors. Front Neurosci. 2017;11:521.","journal-title":"Front Neurosci"},{"key":"640_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nn.2117","volume":"11","author":"PS Lagali","year":"2008","unstructured":"Lagali PS, Balya D, Awatramani GB, M\u00fcnch TA, Kim DS, Busskamp V, et al. Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration. Nat Neurosci. 2008;11:667\u201375.","journal-title":"Nat Neurosci"},{"key":"640_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1126\/science.1190897","volume":"329","author":"V Busskamp","year":"2010","unstructured":"Busskamp V, Duebel J, Balya D, Fradot M, Viney TJ, Siegert S, et al. Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science. 2010;329:413\u20137.","journal-title":"Science"},{"key":"640_CR28","doi-asserted-by":"publisher","first-page":"a041304","DOI":"10.1101\/cshperspect.a041304","volume":"13","author":"A Stefanov","year":"2022","unstructured":"Stefanov A, Flannery JG. A systematic review of optogenetic vision restoration: history, challenges, and new inventions from bench to bedside. Cold Spring Harb Perspect Med. 2022;13:a041304.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"640_CR29","doi-asserted-by":"crossref","unstructured":"Guzman G, Zorn J, Kunze S, Busskamp V. Optogenetische Reaktivierung dormanter Zapfenphotorezeptoren. Die Ophthalmol. 2026;123:262\u20138.","DOI":"10.1007\/s00347-026-02399-8"},{"key":"640_CR30","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1080\/14712598.2022.2012148","volume":"22","author":"L Marrone","year":"2022","unstructured":"Marrone L, Marchi PM, Azzouz M. Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders. Expert Opin Biol Ther. 2022;22:1163\u201376.","journal-title":"Expert Opin Biol Ther"},{"key":"640_CR31","doi-asserted-by":"publisher","first-page":"eaav4523","DOI":"10.1126\/scitranslmed.aav4523","volume":"11","author":"P Tornabene","year":"2019","unstructured":"Tornabene P, Trapani I, Minopoli R, Centrulo M, Lupo M, de Simone S, et al. Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina. Sci Transl Med. 2019;11:eaav4523.","journal-title":"Sci Transl Med"},{"key":"640_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18:358\u201378.","journal-title":"Nat Rev Drug Discov"},{"key":"640_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mt.2009.255","volume":"18","author":"Z Wu","year":"2010","unstructured":"Wu Z, Yang H, Colosi P. Effect of genome Size on AAV vector packaging. Mol Ther. 2010;18:80\u201386.","journal-title":"Mol Ther"},{"key":"640_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrn3783","volume":"15","author":"T Euler","year":"2014","unstructured":"Euler T, Haverkamp S, Schubert T, Baden T. Retinal bipolar cells: elementary building blocks of vision. Nat Rev Neurosci. 2014;15:507\u201319.","journal-title":"Nat Rev Neurosci"},{"key":"640_CR35","doi-asserted-by":"publisher","first-page":"056013","DOI":"10.1088\/1741-2552\/abe39a","volume":"18","author":"M Reh","year":"2021","unstructured":"Reh M, Lee M-J, Schmierer J, Zeck G. Spatial and temporal resolution of optogenetically recovered vision in ChR2-transduced mouse retina. J Neural Eng. 2021;18:056013.","journal-title":"J Neural Eng"},{"key":"640_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15317-6","volume":"11","author":"JE McGregor","year":"2020","unstructured":"McGregor JE, Godat T, Dhakal KR, Parkins K, Strazzeri JM, Bateman BA, et al. Optogenetic restoration of retinal ganglion cell activity in the living primate. Nat Commun. 2020;11:1703.","journal-title":"Nat Commun"},{"key":"640_CR37","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.omtm.2023.05.005","volume":"29","author":"B Yan","year":"2023","unstructured":"Yan B, Viswanathan S, Brodie SE, Deng W-T, Coleman KE, Hauswirth WW, et al. A clinically viable approach to restoring visual function using optogenetic gene therapy. Mol Ther - Methods Clin Dev. 2023;29:406\u201317.","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"640_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s42003-020-01594-w","volume":"4","author":"G Gauvain","year":"2021","unstructured":"Gauvain G, Akolkar H, Chaffiol A, Arcizet F, Khoei MA, Desrosiers M, et al. Optogenetic therapy: high spatiotemporal resolution and pattern discrimination compatible with vision restoration in non-human primates. Commun Biol. 2021;4:125.","journal-title":"Commun Biol"},{"key":"640_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/978-981-15-8763-4_38","volume":"1293","author":"Q Lu","year":"2021","unstructured":"Lu Q, Pan Z-H. Optogenetics, light-sensing proteins and their applications in neuroscience and beyond. Adv Exp Med Biol. 2021;1293:545\u201355.","journal-title":"Adv Exp Med Biol"},{"key":"640_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103430","volume":"87","author":"BL Lam","year":"2025","unstructured":"Lam BL, Zak V, Gonzalez VH, Gregori NZ, Chavala SH, Batabyal S, et al. Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in the USA (STARLIGHT): an open-label multi-center Ph2 trial. eClinicalMedicine. 2025;87:103430.","journal-title":"eClinicalMedicine"},{"key":"640_CR41","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/mt.2015.121","volume":"23","author":"BM Gaub","year":"2015","unstructured":"Gaub BM, Berry MH, Holt AE, Isacoff EY, Flannery JG. Optogenetic vision restoration using rhodopsin for enhanced sensitivity. Mol Ther. 2015;23:1562\u201371.","journal-title":"Mol Ther"},{"key":"640_CR42","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1152\/physrev.1991.71.2.447","volume":"71","author":"H Wassle","year":"1991","unstructured":"Wassle H, Boycott BB. Functional architecture of the mammalian retina. Physiol Rev. 1991;71:447\u201380.","journal-title":"Physiol Rev"},{"key":"640_CR43","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1350-9462(03)00039-9","volume":"22","author":"RE Marc","year":"2003","unstructured":"Marc RE, Jones BW, Watt CB, Strettoi E. Neural remodeling in retinal degeneration. Prog Retin Eye Res. 2003;22:607\u201355.","journal-title":"Prog Retin Eye Res"},{"key":"640_CR44","unstructured":"Study Details | NCT05294978 | EyeConic: Qualification for Cone-Optogenetics | ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT05294978 2026."},{"key":"640_CR45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4103\/tjo.tjo_46_21","volume":"11","author":"HJ Kaplan","year":"2021","unstructured":"Kaplan HJ, Wang W, Piri N, Dean DC. Metabolic rescue of cone photoreceptors in retinitis pigmentosa. Taiwan J Ophthalmol. 2021;11:331\u20135.","journal-title":"Taiwan J Ophthalmol"},{"key":"640_CR46","doi-asserted-by":"publisher","first-page":"13940","DOI":"10.1073\/pnas.1936192100","volume":"100","author":"G Nagel","year":"2003","unstructured":"Nagel G, Szellas T, Huhn W, Kateriya S, Adeishvili N, Berthold P, et al. Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc Natl Acad Sci USA. 2003;100:13940\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"640_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09124-x","volume":"10","author":"MH Berry","year":"2019","unstructured":"Berry MH, Holt A, Salari A, Veit J, Visel M, Levitz J, et al. Restoration of high-sensitivity and adapting vision with a cone opsin. Nat Commun. 2019;10:1221.","journal-title":"Nat Commun"},{"key":"640_CR48","doi-asserted-by":"publisher","first-page":"a041660","DOI":"10.1101\/cshperspect.a041660","volume":"14","author":"V Busskamp","year":"2023","unstructured":"Busskamp V, Roska B, Sahel J-A. Optogenetic vision restoration. Cold Spring Harb Perspect Med. 2023;14:a041660.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"640_CR49","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/cne.902920402","volume":"292","author":"CA Curcio","year":"1990","unstructured":"Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol. 1990;292:497\u2013523.","journal-title":"J Comp Neurol"},{"key":"640_CR50","doi-asserted-by":"publisher","first-page":"8936","DOI":"10.1523\/JNEUROSCI.18-21-08936.1998","volume":"18","author":"C-J Jeon","year":"1998","unstructured":"Jeon C-J, Strettoi E, Masland RH. The Major Cell Populations of the Mouse Retina. J Neurosci. 1998;18:8936\u201346.","journal-title":"J Neurosci"},{"key":"640_CR51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1242\/dmm.017913","volume":"8","author":"S Veleri","year":"2015","unstructured":"Veleri S, Lazar CH, Chang B, Sieving PA, Banin E, Swaroop A. Biology and therapy of inherited retinal degenerative disease: insights from mouse models. Dis Model Mech. 2015;8:109\u201329.","journal-title":"Dis Model Mech"},{"key":"640_CR52","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1167\/iovs.11-8502","volume":"53","author":"PB Henrich","year":"2012","unstructured":"Henrich PB, Monnier CA, Halfter W, Haritoglou C, Strauss RW, Lim RYH, et al. Nanoscale topographic and biomechanical studies of the human internal limiting membrane. Investig Ophthalmol Vis Sci. 2012;53:2561.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"640_CR53","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jconrel.2020.10.028","volume":"328","author":"S Tavakoli","year":"2020","unstructured":"Tavakoli S, Peynshaert K, Lajunen T, Devoldere J, Del Amo EM, Ruponen M, et al. Ocular barriers to retinal delivery of intravitreal liposomes: Impact of vitreoretinal interface. J Control Release. 2020;328:952\u201361.","journal-title":"J Control Release"},{"key":"640_CR54","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.stem.2012.05.009","volume":"10","author":"T Nakano","year":"2012","unstructured":"Nakano T, Ando S, Takata N, Kawada M, Muguruma K, Sekiguchi K, et al. Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell. 2012;10:771\u201385.","journal-title":"Cell Stem Cell"},{"key":"640_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5047","volume":"5","author":"X Zhong","year":"2014","unstructured":"Zhong X, Gutierrez C, Xue T, Hampton C, Vergara MN, Cao L-H, et al. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nat Commun. 2014;5:4047.","journal-title":"Nat Commun"},{"key":"640_CR56","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.stemcr.2017.11.001","volume":"10","author":"T DiStefano","year":"2018","unstructured":"DiStefano T, Chen HY, Panebianco C, Kaya KD, Brooks MJ, Gieser L, et al. Accelerated and improved differentiation of retinal organoids from pluripotent stem cells in rotating-wall vessel bioreactors. Stem Cell Rep. 2018;10:300\u201313.","journal-title":"Stem Cell Rep"},{"key":"640_CR57","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1089\/hum.2018.027","volume":"29","author":"A Gonzalez-Cordero","year":"2018","unstructured":"Gonzalez-Cordero A, Goh D, Kruczek K, Naeem A, Fernando M, Kleine Holthaus S-M, et al. Assessment of AAV vector tropisms for mouse and human pluripotent stem cell\u2013derived RPE and photoreceptor cells. Hum Gene Ther. 2018;29:1124\u201339.","journal-title":"Hum Gene Ther"},{"key":"640_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/tvst.11.4.3","volume":"11","author":"ME McClements","year":"2022","unstructured":"McClements ME, Steward H, Atkin W, Goode EA, G\u00e1ndara C, Chichagova V, et al. Tropism of AAV vectors in photoreceptor-like cells of human iPSC-derived retinal organoids. Transl Vis Sci Technol. 2022;11:3.","journal-title":"Transl Vis Sci Technol"},{"key":"640_CR59","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.stemcr.2016.03.001","volume":"6","author":"M V\u00f6lkner","year":"2016","unstructured":"V\u00f6lkner M, Zsch\u00e4tzsch M, Rostovskaya M, Overall RW, Busskamp V, Anastassiadis K, et al. Retinal organoids from pluripotent stem cells efficiently recapitulate retinogenesis. Stem Cell Rep. 2016;6:525\u201338.","journal-title":"Stem Cell Rep"},{"key":"640_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109397","volume":"27","author":"B Dorgau","year":"2024","unstructured":"Dorgau B, Collin J, Rozanska A, Boczonadi V, Moya-Molina M, Unsworth A, et al. Deciphering the spatiotemporal transcriptional and chromatin accessibility of human retinal organoid development at the single-cell level. iScience. 2024;27:109397.","journal-title":"iScience"},{"key":"640_CR61","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/stem.2963","volume":"37","author":"J Collin","year":"2019","unstructured":"Collin J, Queen R, Zerti D, Dorgau B, Hussain R, Coxhead J, et al. Deconstructing retinal organoids: single cell rna-seq reveals the cellular components of human pluripotent stem cell-derived retina. Stem Cells. 2019;37:593\u20138.","journal-title":"Stem Cells"},{"key":"640_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100915","volume":"83","author":"K Bucher","year":"2021","unstructured":"Bucher K, Rodr\u00edguez-Bocanegra E, Dauletbekov D, Fischer MD. Immune responses to retinal gene therapy using adeno-associated viral vectors \u2013 Implications for treatment success and safety. Prog Retin Eye Res. 2021;83:100915.","journal-title":"Prog Retin Eye Res"},{"key":"640_CR63","unstructured":"Study Details | NCT02556736 | AGN-151597 (Formerly RST-001) Phase I\/II Trial for Advanced Retinitis Pigmentosa | ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT02556736 2026."},{"key":"640_CR64","unstructured":"Study Details | NCT03326336 | Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa | ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT03326336 2026."},{"key":"640_CR65","unstructured":"Study Details | NCT04278131 | BS01 in Patients With Retinitis Pigmentosa | ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT04278131 2026."},{"key":"640_CR66","unstructured":"Study Details | NCT07282457 | Prospective, Randomized, Sham-controlled, Dose-finding I\/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection) | ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT07282457 2026."},{"key":"640_CR67","unstructured":"Open-label, dose escalation, single-dose study of RV-001 in subjects with retinitis pigmentosa (Phase I\/II) (jRCT2033240611). https:\/\/jrct.mhlw.go.jp\/en-latest-detail\/jRCT2033240611 2026."},{"key":"640_CR68","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/d41586-025-00656-5","volume":"639","author":"L Drew","year":"2025","unstructured":"Drew L. Restoring vision with optogenetics. Nature. 2025;639:S7\u2013S9.","journal-title":"Nature"},{"key":"640_CR69","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrg1066","volume":"4","author":"CE Thomas","year":"2003","unstructured":"Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003;4:346\u201358.","journal-title":"Nat Rev Genet"},{"key":"640_CR70","unstructured":"U.S. Food and Drug Administration. Human Gene Therapy for Retinal Disorders: Guidance for Industry. Silver Spring, MD; 2020."},{"key":"640_CR71","doi-asserted-by":"crossref","unstructured":"Thirunavukarasu AJ, Raji S, Kapetanovic JC. Visualising treatment effects in low-vision settings: proven and potential endpoints for clinical trials of inherited retinal disease therapies. Gene Ther. 2026;33:372\u201382.","DOI":"10.1038\/s41434-025-00552-7"},{"key":"640_CR72","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/ceo.13917","volume":"49","author":"M Georgiou","year":"2021","unstructured":"Georgiou M, Fujinami K, Michaelides M. Inherited retinal diseases: therapeutics, clinical trials and end points\u2014a review. Clin Exp Ophthalmol. 2021;49:270\u201388.","journal-title":"Clin Exp Ophthalmol"},{"key":"640_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0445-8","volume":"11","author":"PA Merkel","year":"2016","unstructured":"Merkel PA, Manion M, Gopal-Srivastava R, Groft S, Jinnah HA, Robertson D, et al. The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network. Orphanet J Rare Dis. 2016;11:66.","journal-title":"Orphanet J Rare Dis"},{"key":"640_CR74","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/s41431-017-0008-z","volume":"25","author":"H Lochm\u00fcller","year":"2017","unstructured":"Lochm\u00fcller H, Farnell JTI, Cam YL, Jonker AH, Lau LP, Baynam G, et al. The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact. Eur J Hum Genet. 2017;25:1293\u2013302.","journal-title":"Eur J Hum Genet"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00640-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00640-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00640-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:03:42Z","timestamp":1788339822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00640-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":74,"alternative-id":["640"],"URL":"https:\/\/doi.org\/10.1038\/s41434-026-00640-2","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In the manuscript preparation process, during the preparation of this work, the author used ChatGPT (OpenAI) in order to assist with formatting the manuscript and checking references. After using this tool, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the published article.","order":2,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies","group":{"name":"EthicsHeading","label":"Declarations"}}]}}